Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ONCOGENEX PHARMACEUTICALS Inc OGXI

"OncoGenex Pharmaceuticals Inc is a biopharmaceutical company focused on the development of cancer treatment resistance. It has developed Apatorsen to block the production of heat shock protein 27, or Hsp27, that promotes treatment resistance in cancer."


NDAQ:OGXI - Post by User

Post by pro_traderon Dec 18, 2008 12:12pm
536 Views
Post# 15654383

Stabilizing at the 200 day moving average

Stabilizing at the 200 day moving averageShares of OGXI ook to be stabilizing near the 200 day moving average. We could see another run to 9 very soon. Current price levelsoffer a a very positive risk/reward scenario. Shares should be purchased at current levels as ddown-side volume appears to have dried-up.
Bullboard Posts